Financial Statements — ARAI
Balance Sheet
(in millions USD)| Metric | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 |
|---|
| Cash & Equivalents | 5.67 | 0.82 | 0.61 | 0.30 |
| Short-term Investments | 2.80 | 1.92 | -- | -- |
| Accounts Receivable | 0.00 | 0.00 | 0.09 | -- |
| Total Current Assets | 8.76 | 2.91 | 0.90 | 7.70 |
| Property, Plant & Equipment | 0.68 | 0.15 | 0.13 | 0.09 |
| Intangible Assets | 0.27 | 0.27 | 0.27 | 0.27 |
| Total Non-current Assets | 6.73 | 6.80 | 7.57 | 0.37 |
| Total Assets | 15.49 | 9.71 | 8.47 | 8.07 |
| Accounts Payable | 0.23 | 0.71 | 0.97 | 1.80 |
| Total Current Liabilities | 11.26 | 3.99 | 3.98 | 2.03 |
| Total Non-current Liabilities* | 1.62 | 0.04 | 0.01 | 0.01 |
| Total Liabilities | 12.87 | 4.03 | 3.98 | 2.04 |
| Retained Earnings | (35.12) | (26.01) | (21.59) | (17.90) |
| Total Stockholder Equity* | 2.62 | 5.68 | 4.49 | 6.03 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 |
|---|
| Total Revenue | 0.01 | 0.02 | 0.01 | 0.09 | -- |
| Cost of Revenue | -- | -- | -- | -- | 0.00 |
| Research & Development | 0.36 | 0.04 | 0.18 | 0.29 | 0.09 |
| Selling, General & Admin | 4.21 | 2.80 | 1.37 | 3.47 | 1.99 |
| Total Operating Expenses | 4.68 | 3.00 | 1.66 | 3.82 | -- |
| Interest Expense | -- | -- | 0.17 | -- | 0.00 |
| Pretax Income | (6.37) | (2.73) | (4.43) | (3.69) | (1.98) |
| Net Income | (6.37) | (2.73) | (4.43) | (3.69) | -- |
| Basic EPS | (0.18) | (0.11) | (0.13) | (0.12) | (0.07) |
| Diluted EPS | (0.18) | (0.11) | (0.13) | (0.12) | (0.07) |
Cash Flow Statement
(in millions USD)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 |
|---|
| Operating Cash Flow | (2.93) | (3.20) | (1.25) | (3.25) | (0.55) |
| Capital Expenditures | 0.22 | -- | -- | -- | -- |
| Free Cash Flow* | (3.15) | -- | -- | -- | -- |
| Investing Cash Flow | (3.08) | 1.67 | (1.99) | (0.04) | -0.00 |
| Financing Cash Flow | 9.57 | 2.82 | 3.45 | 3.61 | 0.72 |
* Derived from reported values
